Derma Sciences signs contract to produce finger bandages

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, has finalized a contract with a leading global healthcare products company to produce finger bandages. The agreement is expected to generate a total of approximately $15 million in new revenue for Derma Sciences over a three-year period beginning spring 2010.

"This is an Agreement we have been working on for over one year and our selection is a major step forward in our First Aid Products (FAD) strategy," said Ed Quilty, Chief Executive Officer of Derma Sciences. "These products will be manufactured by Derma for our partner with their specifications under their name. Shipments will begin in early 2010."

Daniel Rivest, President of the First Aid Division of Derma Sciences commented, "The partnership demonstrates our core competencies in private label wound care product manufacturing. This contract was possible due to the successful integration of the First Aid Division into Derma Sciences and our recent manufacturing facility expansion."

Ed Quilty added, "The market can expect to see additional expansion of our private label manufacturing to compliment our efforts in building our proprietary advanced wound care sales highlighted by our MEDIHONEY(TM) line."